HMB for Muscle Loss: What It Does for Older Adults and Bed Rest

By Erin Rose · Updated July 19, 2026 · Methodology

Educational overview — not medical advice. HMB is not an approved treatment for sarcopenia, cachexia, or any other diagnosed muscle-wasting condition; if you or a family member faces significant muscle wasting from illness, hospitalization, or aging, talk to a clinician. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

The cleanest data point: 10 days of bed rest

Deutz et al. 2013 randomized 24 healthy older adults (19 evaluable: 8 control, 11 HMB) to 10 days of complete bed rest followed by 8 weeks of resistance-training rehabilitation, with 3g/day Ca-HMB (1.5g twice daily) starting 5 days before bed rest and continuing through the end of rehab. The primary endpoint — lean body mass change over the bed-rest period — was met: the control group lost 2.05±0.66kg of lean body mass (p=0.02 vs. baseline), while the HMB group's loss was only 0.17±0.19kg (not itself statistically different from zero, but the between-group difference reached significance, p=0.02 by ANOVA). A female subgroup analysis (n=15) also showed a significant between-group difference (p=0.04). The authors explicitly caveat their own result: "differences in function parameters could not be observed, probably due to the sample size," and call for these results "to be confirmed in a larger trial." This is the cleanest attenuates-loss data point in the whole HMB literature — small, honestly caveated, and using bed rest as a real, measurable muscle-wasting model rather than a marketing shortcut.

The broader older-adult signal: mass preserved, strength not shown

Wu et al. 2015, a systematic review and meta-analysis of 7 RCTs (147 HMB-treated + 140 control older adults, 65+, search through September 2014), found HMB produced "greater muscle mass gain in the intervention groups compared with the control groups" (standard mean difference = 0.352kg, 95% CI 0.11–0.594, p=0.004), with no significant fat-mass difference. But the authors' own conclusion draws a careful line: HMB "contributed to preservation of muscle mass in older adults... may be useful in the prevention of muscle atrophy induced by bed rest or other factors. Further studies are needed to determine the precise effects of HMB on muscle strength and physical function." Muscle mass preservation is shown here; muscle strength or physical function is not — a gap the authors name themselves, and one this page does not blur into a broader functional-improvement claim.

The narrower mechanism data: acute muscle protein signaling

Mechanistic tracer studies help explain why a mass-preservation signal is plausible without implying a strength claim. Wilkinson et al. 2013 found HMB-FA increased acute muscle protein synthesis (MPS) 70% and reduced muscle protein breakdown (MPB) 57% in an insulin-independent way — though leucine itself, HMB's parent compound, produced a larger MPS response (110%) at an equal gram dose, a real argument that plain leucine or adequate dietary protein may be the more efficient lever (see BCAAs). Wilkinson et al. 2018 (an MTI-funded academic study) found Ca-HMB produced comparable acute MPS/MPB signaling to HMB-FA. These are real, measured acute biochemical effects — not the same thing as a proven long-term functional outcome, and this page treats them as mechanism, not proof.

What this evidence does not claim

Holeček 2017, an independent narrative review with a disclosed "None declared" conflict-of-interest statement and academic-only funding — the cleanest source in this cluster's entire evidence base — puts it plainly: "HMB is particularly effective in untrained individuals who are exposed to strenuous exercise and in trained individuals who are exposed to periods of high physical stress. The low effectiveness of HMB in strength-trained athletes could be due to the suppression of the proteolysis that is induced by the adaptation to training, which may blunt the effects of HMB." On elderly/wasting populations specifically, the same review states HMB "can attenuate the development of sarcopenia in elderly subjects," but adds "there are few clinical reports of the effects of HMB on muscle wasting in cachexia... most of these studies evaluated the therapeutic potential of combinations of various agents" — meaning cachexia-specific HMB-alone efficacy remains unproven even in this generally HMB-favorable independent review. To be explicit: this page does not claim HMB treats, reverses, prevents, or cures sarcopenia or cachexia. Sarcopenia and cachexia are diagnosed medical conditions; the evidence here supports a narrower claim — modest muscle-mass preservation during disuse or aging, alongside resistance training, not a disease-treatment outcome.

Compare HMB Products

If you're ready to buy, here's how the HMB products we track and verify compare on cost per dose.

Frequently asked questions

Related

• HMB: what it actually does, honestly explained
• HMB dosage guide
• Best HMB — ranked by cost per 3g dose
• Does HMB actually work? — the trained-athlete hype vs. independent evidence
• BCAAs — HMB's parent compound, leucine, is one of the 3 BCAAs

Sources